# olmesartan medoxomil and amlodipine besylate and hydrochlorothiazide

NDC: 70436-014
Generic name: olmesartan medoxomil and amlodipine besylate and hydrochlorothiazide
Labeler / Manufacturer: Slate Run Pharmaceuticals, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, FILM COATED
Routes: ORAL
Marketing started: 20250515

FDA application: ANDA210718

## Active ingredients

- AMLODIPINE BESYLATE: 5 mg/1
- HYDROCHLOROTHIAZIDE: 12.5 mg/1
- OLMESARTAN MEDOXOMIL: 20 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"70436-014"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=70436-014
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a469adff-25a6-4983-b471-60924d920a86